| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $164K | -30.9% |
| SG&A Expense | $1.7M | +20.2% |
| Operating Income | -$3.1M | -17.6% |
| Pre-tax Income | -$3.4M | -12.2% |
| Net Income | -$3.4M | -12.2% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $673K | -73.6% |
| Inventory | $7K | +0.0% |
| Current Assets | $740K | -71.2% |
| Total Assets | $1.5M | -53.4% |
| Current Liabilities | $9.6M | +8.2% |
| Total Liabilities | $9.7M | +8.0% |
| Stockholders' Equity | -$8.1M | -42.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | -47.8% |
| Capital Expenditures | $4K | -33.7% |
| Investing Cash Flow | -$4K | +33.7% |
| Financing Cash Flow | -$35K | +41.3% |
| Free Cash Flow | -$1.8M | -47.4% |